Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Bluefire Renewables, Inc.
SIC 2860 · Industrial Organic Chemicals
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Bluefire Renewables, Inc.
SIC 2860 · Industrial Organic Chemicals
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Bluefire Renewables, Inc.
SIC 2860 · Industrial Organic Chemicals
Notes
Support
about
terms
Bluefire Renewables, Inc.
CIK:
0001370489
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.8.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenues:
Department of Energy grant revenue
Total revenues
Cost of revenue
Gross margin
Operating expenses:
Project development
30,803
General and administrative
102,370
175,925
Total operating expenses
102,370
206,728
Operating loss
(102,370)
(206,728)
Other income and (expense):
Amortization of debt discount
(24,991)
(3,889)
Interest expense
(4,785)
(13,680)
Related party interest expense
(7,684)
(7,147)
Gain from disposal of assets
1,000
Gain (loss) from change in fair value of derivative liability
8,408
(1,021)
Total other income and (expense)
(28,052)
(25,737)
Loss before income taxes
(130,422)
(232,465)
Provision for income taxes
967
Net loss
(131,389)
(232,465)
Net loss attributable to noncontrolling interest
(864)
Net loss attributable to controlling interest
$ (131,389)
$ (231,601)
Basic and diluted loss per common share
$ (0.00)
$ (0.00)
Weighted average common shares outstanding, basic and diluted
771,177,751
408,203,492
v3.8.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:
Net loss
$ (131,389)
$ (232,465)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss (gain) from change in fair value of derivative liability
(8,408)
1,021
Amortization of debt discounts
24,991
3,889
Excess fair value of shares issued
62,714
Gain on disposal of assets
(1,000)
Share based compensation
17,870
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
2,917
(29,167)
Accounts payable
(1,315)
(4,788)
Accrued liabilities
13,369
106,368
Net cash used in operating activities
(20,251)
(155,142)
Cash flows from financing activities:
Proceeds from line of credit/notes payable
25,000
Proceeds from the sale of assets
1,000
Net cash provided by financing activities
26,000
Net change in cash and cash equivalents
5,749
(155,142)
Cash and cash equivalents beginning of period
67
161,991
Cash and cash equivalents end of period
5,816
6,849
Supplemental schedule of non-cash investing and financing activities:
Relief of accrued payables and accrued liabilities through issuance of common stock.
41,695
Derivative liability reclassed to additional paid-in capital
$ 43,240
v3.8.0.1
Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2018
Dec. 31, 2017
Current assets:
Cash and cash equivalents
$ 5,816
$ 67
Prepaid expenses
977
3,894
Total current assets
6,793
3,961
Property and equipment, net of accumulated depreciation of $39,220 and $82,323, respectively
Total assets
6,793
3,961
Current liabilities:
Accounts payable
1,101,892
1,103,207
Accrued liabilities
1,125,822
1,112,453
Convertible accounts payable and accrued liabilities
944,350
986,045
Notes payable
445,000
420,000
Line of credit, related party
256,245
256,245
Note payable to a related party
200,000
200,000
Convertible notes payable, net of discount of $2,499 and $27,489, respectively
47,483
22,492
Derivative liabilities
805,848
858,099
Total current liabilities
4,926,640
4,958,541
Total liabilities
4,926,640
4,958,541
Commitments and contingencies (Note 7)
Redeemable noncontrolling interest
859,377
859,377
Stockholders' deficit:
Preferred stock, no par value, 1,000,000 shares authorized; 51 and 51 shares issued and outstanding as of March 31, 2018, and December 31, 2017, respectively
Common stock, $0.001 par value; 5,000,000,000 shares authorized; 849,726,109 and 499,680,109 shares issued and 849,693,938 and 499,647,938 outstanding, as of March 31, 2018, and December 31, 2017, respectively
849,727
499,681
Additional paid-in capital
16,896,450
17,080,374
Treasury stock at cost, 32,172 shares
(101,581)
(101,581)
Accumulated deficit
(23,423,820)
(23,292,431)
Total stockholders' deficit
(5,779,224)
(5,813,957)
Total liabilities and stockholders' deficit
$ 6,793
$ 3,961